• Most Recent
• Highest Rated
• Hot Comments

Florida BioTechnology News

• Winter Season Marks the Return of Max Planck Florida Institute’s Annual Public Lecture Series

  The Max Planck Florida Institute for Neuroscience (MPFIN) will offer an insider’s view of the mysteries of science when its winter lecture series returns to Palm Beach for a third season. The two-part series is free and open to the public. All lectures are scheduled from 6:30 p.m. – 7:30 [...]

  Share  |  Rate

• New type of nerve cell found in the brain

  Scientists at Karolinska Institutet in Sweden, in collaboration with colleagues in Germany and the Netherlands, have identified a previously unknown group of nerve cells in the brain. The nerve cells regulate cardiovascular functions such as heart rhythm and blood pressure. It is hoped that the discovery, Thyroid hormone is [...]

  Share  |  Rate

• Transplanted genetically-modified adipose cells offer potential therapy for liver diseases

  Using mesenchymal stromal cells derived from adipose (fat) tissues, genetically modified to express a bioluminescent marker, researchers in Italy have tracked cells after transplantation. The cells were followed from their injection into the spleen of mice modeling liver disease, to their characterization as “hepatic precursors,” and to their subsequent migration [...]

  Share  |  Rate

• Biotest receives FDA approval, will produce IVIG in Boca Raton

  Biotest AG announced that Biotest Pharmaceuticals Corporation (BPC) has received FDA approval for BIVIGAMâ„¢ for the treatment of patients with Primary Humoral Immunodeficiency (PI). BIVIGAM is the first polyspecific intravenous immune globulin manufactured in the U.S. by BPC at its Boca Raton facility. This product is being produced for patients [...]

  Share  |  Rate

• Mechanical forces revert and stop the growth of cancer cells

  Researchers at Lawrence Berkeley National Laboratory and UC Berkeley have put the squeeze — literally — on malignant mammary cells to guide them back into a normal growth pattern.

  The findings, presented Monday, Dec. 17 at the annual meeting of the American Society for Cell Biology in San Francisco, show for [...]

  Share  |  Rate

• New Approach to Destroy Disease-Associated RNAs in Cells

  Scientists at Scripps Florida have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.

  Small Molecule-Mediated [...]

  Share  |  Rate

• New approach to suppress spread of cancer

  Scientists at Toronto’s Mount Sinai Samuel Lunenfeld Research Institute have made a major discovery about the way that cancer spreads.  In the paper Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration, published in Cell, Valbona Luga and Dr. Liang Zhang discovered that proteins produced [...]

  Share  |  Rate

• Ultra-sensitive biosensor capable of identifying the smallest single virus particles

  Researchers at Polytechnic Institute of New York University (NYU-Poly) have created an ultra-sensitive biosensor capable of identifying the smallest single virus particles in solution, an advance that may revolutionize early disease detection in a point-of-care setting and shrink test result wait times from weeks to minutes.

  Stephen Arnold, university professor of [...]

  Share  |  Rate

• An invisible knife for noninvasive surgery

  A carbon-nanotube-coated lens that converts light to sound can focus high-pressure sound waves to finer points than ever before. The University of Michigan engineering researchers who developed the new therapeutic ultrasound approach say it could lead to an invisible knife for noninvasive surgery. Carbon-Nanotube Optoacoustic Lens for Focused [...]

  Share  |  Rate

• Scripps Florida Scientists Develop Synthetic Compound that Reverses Fatty Liver Disease

  Scripps Florida researchers have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver. A Liver Selective LXR Inverse Agonist that Suppresses Hepatic Steatosis [...]

  Share  |  Rate